共 4 条
[1]
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
[J].
EUROPACE,
2015, 17 (10)
:1467-1507
Heidbuchel, Hein
;
Verhamme, Peter
;
Alings, Marco
;
Antz, Matthias
;
Diener, Hans-Christoph
;
Hacke, Werner
;
Oldgren, Jonas
;
Sinnaeve, Peter
;
Camm, A. John
;
Kirchhof, Paulus
.
[2]
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label; randomised; controlled trial.[J].Willem JM Dewilde;Tom Oirbans;Freek WA Verheugt;Johannes C Kelder;Bart JGL De Smet;Jean-Paul Herrman;Tom Adriaenssens;Mathias Vrolix;Antonius ACM Heestermans;Marije M Vis;Jan GP Tijsen;Arnoud W van 't Hof;Jurri?n M ten Berg.The Lancet.2013,
[3]
Comparison of the Efficacy and Safety of Two Rivaroxaban Doses in Acute Coronary Syndrome (from ATLAS ACS 2–TIMI 51).[J].Jessica L. Mega;Eugene Braunwald;Stephen D. Wiviott;Sabina A. Murphy;Alexei Plotnikov;Nina Gotcheva;Mikhail Ruda;C. Michael Gibson.The American Journal of Cardiology.2013, 4
[4]
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
[J].
LANCET,
2009, 374 (9683)
:29-38
Mega, J. L.
;
Braunwald, E.
;
Mohanavelu, S.
;
Burton, P.
;
Poulter, R.
;
Misselwitz, F.
;
Hricak, V.
;
Barnathan, E. S.
;
Bordes, P.
;
Witkowski, A.
;
Markov, V.
;
Oppenheimer, L.
;
Gibson, C. M.
.